Is Absci (ABSI) Undervalued On Earnings, A New CCO And Shelf Filing?
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- ABSI Absci
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR
Industrial Select Sector SPDR holds the industrials sector that Absci belongs to, so it often moves with news about it.
- IQV IQVIA Holdings
IQVIA Holdings is a peer of Absci in commercial physical and biological research; rivals often move on the same news.
- INCY Incyte
Incyte is a peer of Absci in commercial physical and biological research; rivals often move on the same news.
- MEDP Medpace Holdings
Medpace Holdings is a peer of Absci in commercial physical and biological research; rivals often move on the same news.
- CRL Charles River Laboratories International
Charles River Laboratories International is a peer of Absci in commercial physical and biological research; rivals often move on the same news.
- ICLR ICON Public
ICON Public is a peer of Absci in commercial physical and biological research; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ABSI | +27.75% | +19.23% | base | after close | after close | after close | after close |
| XLI | +0.05% | +1.29% | base | after close | after close | after close | after close |
| IQV | +5.23% | +3.57% | base | after close | after close | after close | after close |
| INCY | +0.76% | +1.05% | base | after close | after close | after close | after close |
| MEDP | +3.01% | +1.71% | base | after close | after close | after close | after close |
| CRL | +4.56% | +1.30% | base | after close | after close | after close | after close |
| ICLR | +6.54% | +2.36% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Is Absci (ABSI) Undervalued On Earnings, A New CCO And Shelf Filing? Simply Wall St
Source: Simply Wall St
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABSI | three days earlier | +19.23% | final price |
| ABSI | five days earlier | +27.75% | final price |
| CRL | three days earlier | +1.30% | final price |
| CRL | five days earlier | +4.56% | final price |
| ICLR | three days earlier | +2.36% | final price |
| ICLR | five days earlier | +6.54% | final price |
| INCY | three days earlier | +1.05% | final price |
| INCY | five days earlier | +0.76% | final price |
| IQV | three days earlier | +3.57% | final price |
| IQV | five days earlier | +5.23% | final price |
| MEDP | three days earlier | +1.71% | final price |
| MEDP | five days earlier | +3.01% | final price |
| XLI | three days earlier | +1.29% | final price |
| XLI | five days earlier | +0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 62 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 68 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 73 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 72 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 51 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Is Absci (ABSI) Undervalued On Earnings, A New CCO And Shelf Filing?” scores 12 out of 100. The score uses 1 sources.